Live talk
Join us every other Thursday at 3:00 pm PST for a discussion on the latest developments in the management and treatment of pituitary disease with leading specialists and experts in the field. Stay tuned for an announcement on our next program click here to join the studio
Read more about Live Talk here – Listen to our past sessions on demand.
Articles of note for people dealing with pituitary disease and related conditions.
Join a drug trial. Find out how. Here’s a partial list of studies.
Brief, insightful commentary from Dr. Lewis Blevins on issues of relevance to pituitary disease.
Live-talk, session 23 – insights on medicine and mental health: a perspective
Today's program focuses on interactions between the medical and psychological worlds. Join Dr. Blevins and me as we welcome PWN contributor, marriage and family therapist, and author Linda Rio for a fascinating discussion on how pituitary disease, or any chronic disease, manifests itself mentally and emotionally. Listen as we muse on how emotional health and psychological distress can affect people's daily lives and how they deal with their disorders.
Helping medical students learn about acromegaly
After a few virtual meetings these past years, I was back at UC Berkeley/UCSF's joint medical program for an in-person gathering with some of the brightest and most engaged medical students on the planet. This is, without a doubt, one of my favorite things to do since founding PWN, and I look forward to it every year.
News In Brief
Crinetics Pharmaceuticals announces Phase 3 PATHFNDR-1 study complete; PATHFNDR-2 study of oral paltusotine for acromegaly enrollment ongoing, and anticipates seeking FDA application submission in 2024. Learn more about #paltusotine and #acromegaly. …Read more
Recordati Rare Diseases Introduces Cushing’s Conversations, a new support program for people who have been prescribed ISTURISA®. Read more
Amryt Pharma relaunches its patient-facing website for Mycapssa
Corcept Therapeutics announces new communication materials for Phase 3 Trial of Relacolirant in patients with Cushing’s syndrome. Click here to learn more and see if you qualify.
Content for physicians and healthcare professionals.
The latest from pharmaceutical companies and related organizations
Latest trends and a roundup of health and wellness news
The Podcast
Knowledge and information are critical tools to affect early diagnosis in pituitary disease. Join Dr. Lewis Blevins and Jorge D Faccinetti cofounders, as they navigate the wonders and complexities of pituitary conditions.
Meet Laura Cheng. Laura is a nurse. She has acromegaly. She works as a clinical nurse and is currently enrolled in the endocrine program at Duke University. Laura's connection to this disease gives her a unique perspective and will provide an invaluable resource to her patients. We caught up with Laura a few weeks ago. This is her story.
In our first live-talk session of 2023, we focus on critical topics, including insurance delay trends affecting pituitary medical practices, interesting clinical cases we can learn from, where telemedicine is going after the Covid era, and more commentary from the subjects we covered in our recent "briefing and insights" article.
Today we present an excellent discussion with Dr. Alan Krasner, Chief Medical Officer for Crinetics Pharmaceuticals. Dr. Krasner speaks to PWN about two very important drugs currently under development.
Subscribe & Listen
Apple Podcasts
Spotify
Amazon Music
Google PodcastsLive Talk on Demand
Events
More details and book your pass here
If you missed the live event, here is the recorded session with critical information on navigating Medicare.
